Clinical trial of focal segmental glomerulosclerosis in children and young adults
Debbie S. Gipson(University of Michigan–Ann Arbor), Aaron L. Friedman(University of Minnesota), Susan L. Hogan(University of North Carolina at Chapel Hill), Frederick J. Kaskel(Montefiore Medical Center), Tom Greene(University Medical Center Groningen), Patti A. Flynn(Yeshiva University), Ronald J. Hogg, Howard Trachtman(University of Michigan), Norman J. Siegel, Jennifer Gassman(Cleveland Clinic), Milena Radeva(Cleveland Clinic), June L. McMahan(Cleveland Clinic), John P. Middleton(Duke University), Suzanne Vento(Long Island Jewish Medical Center), V. Matti Vehaskari(Children's Hospital of New Orleans), Vivette D. D’Agati(Columbia University), Sandra L. Watkins(University of Washington), Leslie Powell(University of North Carolina at Chapel Hill), Richard Ν. Fine(Stony Brook University Hospital), Marva Moxey‐Mims(National Institutes of Health)
Cited by 241
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
|Nature Genetics|1997|869